Ad hoc news

to the archive

Corestate Capital Holding S.A.: Approval of securities prospectus and capital increase by means of a private placement

09/29/2016
DGAP-Ad-hoc: Corestate Capital Holding S.A.: Approval of securities prospectus and capital increase by means of a private placement

Corestate Capital Holding S.A. / Key word(s): IPO/Capital Increase
29.09.2016 10:11

Disclosure of an inside information according to Article 17 MAR, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
CORESTATE Capital Holding S.A.: Approval of securities prospectus and capital increase by means of a private placement

On 29 September 2016 the Luxembourg Financial Supervisory Authority (CSSF) has approved the securities prospectus of Corestate Capital Holding S.A. (“Corestate” or “the Company”) and has notified the approval of the securities prospectus to the German Federal Financial Supervisory Authority. The listing of the shares of Corestate is scheduled for 4 October 2016 on the Frankfurt Stock Exchange. All 12,610,681 shares (ISIN LU1296758029/WKN A141J3) shall be included to trading on the Frankfurt Stock Exchange via the Entry Standard.

Immediately prior to the approval of the securities prospectus, Corestate has completed a capital increase by means of a private placement with an issue price of EUR 17 per share to selected international investors. The gross proceeds from the capital increase amounted to around EUR 43 million.
The securities prospectus will be published by Corestate on the homepage of the Company without undue delay.

CORESTATE Capital Holding S.A.
CORESTATE Capital Holding S.A. is a fully integrated real estate investment manager and co-investor based in Luxembourg that also has offices in Frankfurt, Zurich, London and Singapore. Since the foundation of CORESTATE in 2006 the transaction volume amounts to approximately EUR 5.6 billion. CORESTATE accompanies its customers along the entire value creation chain of a real estate investment product and covers, in particular, deal sourcing and the development of investment products, structuring and execution of transactions, real estate investment management services and the development and execution of exit strategies.

Investor Relations Contact
Henryk Deter / Mirko Koch
cometis AG
Phone: +49 0611 20585540
koch@cometis.de

Press Contact
Tom Zeller, Managing Partner
Feldhoff & Cie. GmbH
Phone: +49 69 264867715
Cell phone: +49 176 10430063
tz@feldhoff-cie.de

DISCLAIMER:

This publication constitutes neither an offer to sell nor a solicitation of an offer to purchase securities. The securities that are the subject of the listing discussed in this press release have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold in the United States absent registration or an available exemption from the registration requirements of the Securities Act.

In the United Kingdom, this publication is directed only at persons who: (i) are qualified investors within the meaning of the Financial Services and Markets Act 2000 (as amended) and any relevant implementing measures and/or (ii) are outside the United Kingdom or (iii) have professional experience in matters relating to investments and fall within the definition of “investment professionals” contained in article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Order”) or are persons falling within article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Order, or fall within another exemption to the Order (all such persons referred to in (i) to (iii) above together being referred to as “Relevant Persons”). Any person who is not a Relevant Person must not act or rely on this publication or any of its contents. Any investment or investment activity to which this publication relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. This publication contains statements related to future business and financial performance and future events or developments involving CORESTATE that may constitute forward-looking statements. These statements may be identified by words such as “expect”, “intend”, “look forward to”, “believe”, “will” or other words of similar meaning. Such statements are based on current expectations and certain assumptions of CORESTATE ‘s management, of which many are out of our control. These are subjects to a number of risks and uncertainties. Should one or more of this risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of CORESTATE may (negatively or positively) vary materially from those described explicitly or implicitly in the relevant forward-looking statement. CORESTATE does not intend or assume any obligation to update or revise these forward-looking statements in light of developments which differ from those anticipated.
This publication is not a prospectus. Investors should not purchase or subscribe for any securities
referred to in this publication except on the basis of information in the prospectus to be issued by
CORESTATE in connection with the offering of such securities.

29.09.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de